Suggestions
Claudia Beqaj
Vice President @ Celltrion USA | Immunology Marketing and Sales
Claudia Beqaj is a seasoned biopharma commercialization professional currently serving as the Vice President of Immunology Sales at Celltrion USA.12 With over 20 years of hands-on experience in the industry, she has established herself as a leader in immunology marketing and sales.2
Professional Background
Prior to her role at Celltrion USA, Claudia held significant positions in other pharmaceutical companies:
- Executive Director, Specialty Sales and Marketing, Dermatology at Boehringer Ingelheim Pharmaceuticals, Inc.7
- Executive Director, Dermatology at Boehringer Ingelheim, where she led her team through a successful product launch8
Achievements and Recognition
Claudia's expertise and leadership in the pharmaceutical industry have earned her notable recognition:
- Named as an ELITE 2023 Launch Expert by PM360, a prestigious honor in the pharmaceutical and healthcare marketing industry7
- Awarded the PM360 2023 Trailblazer Award as a Dermatology Brand Champion8
Professional Interests and Activities
Claudia demonstrates a strong commitment to patient care and healthcare education:
- She actively participates in raising awareness about rare diseases to help patients3
- Claudia shows enthusiasm for initiatives that educate healthcare providers, such as the American Academy of Dermatology's new program4
Her LinkedIn profile (username: claudia-beqaj-b9768b4) serves as a platform where she shares industry insights, celebrates achievements in healthcare education, and engages with other professionals in the field.56
Highlights
Exciting news!
Today the American Academy of Dermatology (AAD) has launched an incredible new initiative to educate healthcare providers about Generalized Pustular Psoriasis (#GPP).
Leveraging the power of the AAD DataDerm platform, this program aims to improve understanding, provide valuable resources, and enhance treatment outcomes for GPP patients. I applaud the AAD for their ongoing commitment to patient care and advancing dermatological knowledge.
I am thrilled and humbled to announce that I have been selected as a 2023 Clio Health Innovators honoree! I want to extend my deepest appreciation to my larger team, whose unwavering support and dedication have been instrumental to this achievement. This recognition serves as a reminder that innovation is a collective effort and that together, we have the power to shape the future of healthcare and improve the lives of patients living with rare diseases.
You can see the full list of recipients here: https://lnkd.in/eCTCc2BG
